Syngene launches platform for rapid, enhanced protein production tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
The new proprietary cell line development platform combines a robust cell line, transposon technology with high throughput clone screening and single cell imaging to deliver highly efficient
/PRNewswire/ The global allergy immunotherapies market size is estimated to grow by USD 1.18 billion from 2024-2028, according to Technavio. The market is.
Merck KGaA (OTCMKTS:MKGAF – Get Free Report) shares hit a new 52-week high on Wednesday . The company traded as high as $189.65 and last traded at $187.00, with a volume of 141 shares changing hands. The stock had previously closed at $178.00. Merck KGaA Stock Up 5.1 % The stock has a market capitalization […]